Source: MarketScreener

EOC: Immutep : Partner, EOC Pharma, Continues to Advance Efti in Breast Cancer

(marketscreener.com) ASX/Media Announcement Immutep's Partner, EOC Pharma, Continues to Advance Efti in Breast Cancer SYDNEY, AUSTRALIA - April 8th, 2020 - Immutep Limited , is pleased to inform that EOC Pharma and Immutep jointly discussed the current AIPAC results and confirmed plans...https://www.marketscreener.com/IMMUTEP-LIMITED-38892320/news/Immutep-Partner-EOC-Pharma-Continues-to-Advance-Efti-in-Breast-Cancer-30382036/?utm_medium=RSS&utm_content=20200407

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Xiaoming Zou's photo - Co-Founder & CEO of EOC Pharma

Co-Founder & CEO

Xiaoming Zou

CEO Approval Rating

90/100

Read more